Brian Higgins
Impact in
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Heat shock proteins research
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Oncology top 10%
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
Papers in
- Genetics 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
-
- Acute Myeloid Leukemia Research 5
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- David B. AgusHoward I. ScherCarlos Cordon‐CardoP A MarksVictoria M. RichonLisa M. ButlerR A RifkindAaron H. Rose
- Journals
- Blood (5 papers)Journal of Clinical Oncology (3 papers)Molecular Cancer Therapeutics (1 paper)HemaSphere (1 paper)Cell Cycle (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Brian Higgins
25 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Molecular Biology 1.2k
- Oncology 444
- Pulmonary and Respiratory Medicine 436
- Cancer Research 198
- Immunology 138
Countries citing papers authored by Brian Higgins
This map shows the geographic impact of Brian Higgins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Higgins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Higgins more than expected).
Fields of papers citing papers by Brian Higgins
This network shows the impact of papers produced by Brian Higgins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Higgins. The network helps show where Brian Higgins may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brian Higgins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 2 | |
| 6 | 2021 | 1 | |
| 7 | 2020 | 9 | |
| 8 | 2013 | 20 | |
| 9 | 2011 | 1 | |
| 10 | 2010 | 11 | |
| 11 | 2010 | 24 | |
| 12 | 2010 | 27 | |
| 13 | Novel regimens of capecitabine alone and combined with irinotecan and bevacizumab in colorectal cancer xenografts. | 2009 | 16 |
| 14 | Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer. | 2002 | 83 |
| 15 | 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts. | 2002 | 354 |
| 16 | Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. | 2001 | 105 |
| 17 | A potential role for activated HER-2 in prostate cancer. | 2000 | 36 |
| 18 | Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Hit paper breakdown → | 2000 | 521 |
| 19 | Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. | 2000 | 125 |
| 20 | Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models. | 1999 | 123 |
About Brian Higgins
Brian Higgins is a scholar working on Genetics, Hematology, Oncology, Cancer Research and Modeling and Simulation, having authored 26 papers that have together received 1.6k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), HER2/EGFR in Cancer Research (6 papers), Acute Myeloid Leukemia Research (5 papers), Cancer Treatment and Pharmacology (5 papers), Ubiquitin and proteasome pathways (5 papers), Prostate Cancer Treatment and Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Kruppel-like factors research (3 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Oncology (444 citations), Pulmonary and Respiratory Medicine (436 citations), Cancer Research (198 citations) and Immunology (138 citations). Brian Higgins has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include David B. Agus, Howard I. Scher, Carlos Cordon‐Cardo, P A Marks, Victoria M. Richon, Lisa M. Butler, R A Rifkind, Aaron H. Rose, H Thaler and Marija Drobnjak. Their work appears in journals such as Blood, Journal of Clinical Oncology, Molecular Cancer Therapeutics, HemaSphere and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.